Monoclonal antibody | |
---|---|
Type | Whole antibody |
Source | Chimeric (mouse/human) |
Target | 5AC |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 1092658-06-4 |
ATC code | None |
UNII | F988K568V2 |
Chemical data | |
Formula | C6342H9800N1678O1985S46 |
Mol. mass | 142.8 kDa |
(verify) |
(what is this?)
Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.[1]
Ensituximab was developed by Neogenix Oncology, Inc.